(Q36491903)

14 August 2017

1 reference

title

"Natural" or alternative medications for migraine prevention (English)

1 reference

14 August 2017

1 reference

1

Randolph W Evans

1 reference

14 August 2017

Frederick R Taylor

2

1 reference

14 August 2017

publication date

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

46

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

1012-1018

1 reference

Factors associated with the onset and remission of chronic daily headache in a population-based study

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Feverfew as a preventive treatment for migraine: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Herbal medicines in migraine prevention Randomized double-blind placebo-controlled crossover trial of a feverfew preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Petasites hybridus root (butterbur) is an effective preventive treatment for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Safety of a patented special butterbur root extract for migraine prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

Melatonin, the pineal gland and their implications for headache disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00473.X

10.1111/J.1526-4610.2006.00473.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference